- Profile
- Personal Information
- Publications
Experts in Toxicology
Dr. Rama Kant Singh KREMZER Oleksandr Andreevich Vladimir Katanaev Marie-Christine Broillet Karen L. Martin Rhonda Rosengren Lauren Aleksunes Kenneth Bart Kousik Pramanick Shankar Munusamy Dr. Sharad Sharma Dr. Srikanta Kumar Rath DR. Raj Kamal Tripathi Dr. Aamir Nazir Dr. Sarika Singh Kenneth S. Korach Danielle Carlin Freya Kamel Abhayachandran.K Dr. Pradeep Bhatnagar View MoreBiography
Paul E. Freiman currently serves as Chairman of Penwest Pharmaceutical Co., and serves on the boards of Calypte Biomedical Corporation, NeoPharm, Inc., Otsuka America Pharmaceuticals, Inc., and SciGen Ltd. Mr. Freiman was most recently the President and CEO of Neurobiological Technologies Inc. Prior to this role, he held the position of Chairman and CEO of Syntex Corporation, which was sold to The Roche Group for $5.3 billion during his tenure. Mr. Freiman holds a B.S. degree in pharmacy from Fordham University and an honorary doctorate from the Arnold & Marie Schwartz College of Pharmacy.
Research Intrest
Pharmaceutical, Neurobiologics, Pharmacology